Psychotropic medication use in early pregnancy: impacts on child socio‐emotional and behavioral development

BACKGROUND: Clinical symptoms of distress (anxiety or depression) affect around 10%-25% of women during the perinatal period, which, if left untreated, can adversely affect both maternal health and child development. Psychotropic medications are often first-line treatments for maternal distress in pregnancy, but their effects on child socio-emotional development remain underexplored. This study aims to compare socio-emotional and behavioral development of children at 18 and 36 months according to early pregnancy exposure to treated or untreated maternal distress. METHODS: This project is based on the Montreal Antenatal Well-Being Study, a prospective cohort study of 1,130 pregnant individuals from Quebec, Canada. Women self-reported their medication use and were categorized as: (1) Untreated maternal distress, (2) Psychotropic medication use, (3) Control group (no maternal distress, no psychotropic medication). Analyses of covariance were used to examine the associations between exposure groups and indices of child socio-emotional and behavioral development, assessed using the Early Childhood Behavior Questionnaire and the Child Behavior Checklist. To better account for baseline symptom severity and treatment indication, propensity score weighting was used to create comparable groups with balanced covariates such as socioeconomic status and health care access. RESULTS: Approximately 9.4% of women reported psychotropic medication use in early pregnancy. Analyses of covariance showed that maternal psychotropic medication use was associated with child inhibited temperament at 18 months and greater social withdrawal at 36 months. Propensity weighting revealed that these associations were largely driven by unmeasured confounding, showing no lasting associations with medication. In contrast, children born to mothers with untreated distress had poorer socio-emotional development. CONCLUSIONS: Our findings underscore the critical importance of appropriate statistical control of confounding in observational studies of maternal medication use and child outcomes. They also emphasize the impact of maternal distress on child development and the need for access to effective perinatal treatments.

Authors

Institutions

Publication Details

Journal
Journal of Child Psychology and Psychiatry
Published
2026-11-17
DOI
https://doi.org/10.1111/jcpp.70255
Primary Topic
Maternal Mental Health During Pregnancy and Postpartum
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Psychotropic medication use in early pregnancy: impacts on child socio‐emotional and behavioral development

Simone Natalie Vigod, Guillaume Elgbeili, Gillian E. Hanley, Tim F. Oberlander et al.
Journal of Child Psychology and Psychiatry
Maternal Mental Health During Pregnancy and Postpartum
article

Psychotropic medication use in early pregnancy: impacts on child socio‐emotional and behavioral development

Simone Natalie Vigod, Guillaume Elgbeili, Gillian E. Hanley, Tim F. Oberlander, Tina C. Montreuil, Marion Lecorguillé, Cindy‐Lee Dennis, Cindy Hénault Robert, Kieran J. O'Donnell
article en

Abstract

BACKGROUND: Clinical symptoms of distress (anxiety or depression) affect around 10%-25% of women during the perinatal period, which, if left untreated, can adversely affect both maternal health and child development. Psychotropic medications are often first-line treatments for maternal distress in pregnancy, but their effects on child socio-emotional development remain underexplored. This study aims to compare socio-emotional and behavioral development of children at 18 and 36 months according to early pregnancy exposure to treated or untreated maternal distress. METHODS: This project is based on the Montreal Antenatal Well-Being Study, a prospective cohort study of 1,130 pregnant individuals from Quebec, Canada. Women self-reported their medication use and were categorized as: (1) Untreated maternal distress, (2) Psychotropic medication use, (3) Control group (no maternal distress, no psychotropic medication). Analyses of covariance were used to examine the associations between exposure groups and indices of child socio-emotional and behavioral development, assessed using the Early Childhood Behavior Questionnaire and the Child Behavior Checklist. To better account for baseline symptom severity and treatment indication, propensity score weighting was used to create comparable groups with balanced covariates such as socioeconomic status and health care access. RESULTS: Approximately 9.4% of women reported psychotropic medication use in early pregnancy. Analyses of covariance showed that maternal psychotropic medication use was associated with child inhibited temperament at 18 months and greater social withdrawal at 36 months. Propensity weighting revealed that these associations were largely driven by unmeasured confounding, showing no lasting associations with medication. In contrast, children born to mothers with untreated distress had poorer socio-emotional development. CONCLUSIONS: Our findings underscore the critical importance of appropriate statistical control of confounding in observational studies of maternal medication use and child outcomes. They also emphasize the impact of maternal distress on child development and the need for access to effective perinatal treatments.

Journal of Child Psychology and Psychiatry
University of British Columbia (CA), University of Toronto (CA), Lunenfeld-Tanenbaum Research Institute (CA), Douglas Mental Health University Institute (CA), McGill University Health Centre (CA), Women's College Hospital (CA), Yale University (US), Women's Health Research Institute (CA), B.C. Women's Hospital & Health Centre (CA), BC Children's Hospital Research Institute (CA), Research Institute of the McGill University Health Centre (CA), Women’s College Hospital Research and Innovation Institute (CA), McGill University (CA)
Brain and Behavior Research Foundation, Canadian Institute for Advanced Research, McGill University, Children's Hospital Foundation, Centre hospitalier universitaire Sainte-Justine, Canada First Research Excellence Fund, Fondation de l'Hôpital de Montréal pour enfants, Ludmer Centre for Neuroinformatics and Mental Health, Fonds de Recherche du Québec - Santé
Good health and well-being
Maternal Mental Health During Pregnancy and Postpartum
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon